Cross-sectional study to investigate the occurence and severity of signs and symptoms of ocular surface disease in patients with ongoing chronic topical treatment for glaucoma or ocular hypertension.

Santen Oy0 个研究点目标入组 880 人开始时间: 2010年12月8日最近更新: 2012年5月29日

试验速览

暂无简介。

•Patients of any race and either sex meeting all of the following criteria will be considered eligible for this study:
•Glaucoma patients:
•1. Aged 18 years or more
•2. Diagnosis of glaucoma/OH: primary open angle glaucoma, pseudoexfoliation glaucoma, pigmentary glaucoma, ocular hypertension (being treated)
•3. Are willing to follow instructions
•4. Have provided a written informed consent
•Control patients (equal number of males and females at each center):
•1. Aged 40 years or older
•2. No prior or current use of ocular hypertensive medications
•3. Willing to follow instructions
•4. Have provided written informed consent
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•1. Current participation in another clinical trial involving an investigational drug/device, or participation in such a trial within the last 30 days
•2. Eye surgery performed within the last 6 months
•3. Patients with known or seasonal allergy
•4. Known alcoholism, or other drug abuse that could influence the variables to be studied

发起方